Clinical Trials Browser

Phase 2 × HER2-positive Gastric Cancer × Trastuzumab × Clear all

NCT06439550 2024-06-03

Adjuvant Treatment With Serplulimab，Trastuzumab and SOX in the HER-2 Positive GC/GEJC

Phase 2 Not yet recruiting

Gastrointestinal

HER2-positive Gastric Cancer

NCT05311189 2022-04-05

Study of HLX10, Trastuzumab and Chemotherapy in First-line Treatment of HER2-positive Recurrent/Metastatic Gastric Cancer

Phase 2 Unknown

Gastrointestinal

HER2-positive Gastric Cancer